Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) 347.3496.47-

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 347.34 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025347.34
Mar202496.47
Mar2023-

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2025 347.34
260.05
Mar2024 96.47
0
Mar2023 0 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹50.9 Cr -5.8% -24.2% -52.3% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,059.8 Cr -4.2% -10.8% -19.8% Stock Analytics
KIRI INDUSTRIES ₹2,259.9 Cr -2% -12.8% -35.7% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,355.0 Cr -6% -12% -38.1% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹983.4 Cr -3.1% -11.6% 5.1% Stock Analytics
BODAL CHEMICALS ₹613.9 Cr 6.6% -2.2% -30.9% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-5.8%

-24.2%

-52.3%

SENSEX

-2.4%

-10.9%

0.2%


You may also like the below Video Courses